157 related articles for article (PubMed ID: 27271007)
1. Efficient treatment allocation in 2 × 2 cluster randomized trials, when costs and variances are heterogeneous.
Lemme F; van Breukelen GJ; Berger MP
Stat Med; 2016 Oct; 35(24):4320-4334. PubMed ID: 27271007
[TBL] [Abstract][Full Text] [Related]
2. Efficient treatment allocation in 2 × 2 multicenter trials when costs and variances are heterogeneous.
Lemme F; van Breukelen GJP; Candel MJJM
Stat Med; 2018 Jan; 37(1):12-27. PubMed ID: 28948651
[TBL] [Abstract][Full Text] [Related]
3. The effect of heterogeneous variance on efficiency and power of cluster randomized trials with a balanced 2 × 2 factorial design.
Lemme F; van Breukelen GJ; Candel MJ; Berger MP
Stat Methods Med Res; 2015 Oct; 24(5):574-93. PubMed ID: 25911332
[TBL] [Abstract][Full Text] [Related]
4. Maximin design of cluster randomized trials with heterogeneous costs and variances.
van Breukelen GJP; Candel MJJM
Biom J; 2021 Oct; 63(7):1444-1463. PubMed ID: 34247406
[TBL] [Abstract][Full Text] [Related]
5. Efficient design of cluster randomized trials with treatment-dependent costs and treatment-dependent unknown variances.
van Breukelen GJP; Candel MJJM
Stat Med; 2018 Sep; 37(21):3027-3046. PubMed ID: 29888393
[TBL] [Abstract][Full Text] [Related]
6. Repairing the efficiency loss due to varying cluster sizes in two-level two-armed randomized trials with heterogeneous clustering.
Candel MJ; Van Breukelen GJ
Stat Med; 2016 May; 35(12):2000-15. PubMed ID: 26756696
[TBL] [Abstract][Full Text] [Related]
7. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
van Breukelen GJ; Candel MJ
Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
[TBL] [Abstract][Full Text] [Related]
8. Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.
Tong G; Taljaard M; Li F
Stat Med; 2023 Aug; 42(19):3392-3412. PubMed ID: 37316956
[TBL] [Abstract][Full Text] [Related]
9. Efficient treatment allocation in two-way nested designs.
Lemme F; van Breukelen GJ; Berger MP
Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
[TBL] [Abstract][Full Text] [Related]
10. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.
Candel MJ; van Breukelen GJ
Stat Methods Med Res; 2015 Oct; 24(5):557-73. PubMed ID: 25519890
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical Bayesian modeling of heterogeneous outcome variance in cluster randomized trials.
Tong G; Tong J; Jiang Y; Esserman D; Harhay MO; Warren JL
Clin Trials; 2024 Jan; ():17407745231222018. PubMed ID: 38197388
[TBL] [Abstract][Full Text] [Related]
12. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
[TBL] [Abstract][Full Text] [Related]
13. Maximin Efficiencies under Treatment-Dependent Costs and Outcome Variances for Parallel, AA/BB, and AB/BA Designs.
Candel MJJM
Comput Math Methods Med; 2018; 2018():8025827. PubMed ID: 30402138
[TBL] [Abstract][Full Text] [Related]
14. Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms.
Copas AJ; Hooper R
Stat Med; 2021 Nov; 40(25):5474-5486. PubMed ID: 34312902
[TBL] [Abstract][Full Text] [Related]
15. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.
Moerbeek M
Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807
[TBL] [Abstract][Full Text] [Related]
16. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.
Jaki T; Vasileiou D
Stat Med; 2017 Feb; 36(4):563-580. PubMed ID: 27804166
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of standardised mean differences from randomised trials with treatment-related clustering associated with care providers.
Walwyn R; Roberts C
Stat Med; 2017 Mar; 36(7):1043-1067. PubMed ID: 27910117
[TBL] [Abstract][Full Text] [Related]
18. The use of permutation tests for the analysis of parallel and stepped-wedge cluster-randomized trials.
Wang R; De Gruttola V
Stat Med; 2017 Aug; 36(18):2831-2843. PubMed ID: 28464567
[TBL] [Abstract][Full Text] [Related]
19. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
Sverdlov O; Ryeznik Y
Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
[TBL] [Abstract][Full Text] [Related]
20. Incorporating cost in power analysis for three-level cluster-randomized designs.
Konstantopoulos S
Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
